Allstate Corp SEC Filings

The Allstate Corporation furnished a Form 8-K under Regulation FD to make available its September 2025 monthly release. The update, posted on allstateinvestors.com and attached as Exhibit 99, announces estimated catastrophe losses and policies in force. The company states the exhibit is furnished and not filed pursuant to Instruction B.2.

This is an informational disclosure intended to provide investors with the latest monthly catastrophe loss estimates and policy counts; specific figures were not included in the excerpt.

Thomas J. Wilson, Chairman, President & CEO of The Allstate Corporation (ALL), reported open-market sales executed under a Rule 10b5-1 trading plan adopted on 06/27/2025. On 10/06/2025 he sold a total of 16,807 shares in three reported transactions with weighted average prices of $209.6272, $210.4799, and $211.1514; reported sale price ranges were $209.070–$211.280.

After these transactions the reporting person shows 212,040.491 shares held directly and several indirect holdings through trusts and plans totaling 785,718 shares (listed by vehicle). The Form 4 states the sales were effected pursuant to the trading plan and discloses dividend reinvestment activity adding 33.037 shares during April–October 2025.

Mario Rizzo, listed as Chief Operating Officer-AIC of The Allstate Corporation (ALL), reported changes in his beneficial ownership on 10/03/2025 via a Form 4. The filing shows 199 shares acquired upon conversion of a 2022 performance stock award and 89 shares withheld for tax obligations, leaving 68,814 shares reported as directly beneficially owned after the transactions. The report also discloses 1,662 shares held indirectly through a 401(k) plan. In derivative holdings, 224 employee stock options were reported as acquired with an exercise price of $210.82 and an expiration in 2035, and 57 restricted stock units (RSUs) were granted that convert in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The Form is signed by an attorney-in-fact on 10/07/2025.

Allstate Corporation (ALL) reporting person Jesse E. Merten completed equity transactions tied to long‑term awards and an option exercise in early October 2025. On 10/05/2025 538 shares were acquired on conversion of a 2022 performance stock award and 239 shares were withheld to cover tax obligations related to that conversion. Separately, an employee stock option with a $210.82 exercise price was exercised on 10/03/2025 producing 213 underlying shares, and 54 restricted stock units were granted on 10/03/2025 that vest in three equal increments through 10/03/2028. Following these actions, the reporting person beneficially owned 21,526 shares directly and 7,706 shares indirectly via a 401(k) plan.

Insider award of 7,115 restricted stock units at no cost, vesting in three equal annual installments. An executive officer, Zulfikar Jeevanjee (EVP & CTO - AIC), was granted 7,115 Restricted Stock Units (RSUs) on 10/03/2025 under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU converts to one share of Allstate common stock without payment on the conversion dates. The RSUs vest in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The reported grant shows 0 purchase price per unit and results in 7,115 shares beneficially owned following the award.

Allstate Corporation reported that its Chief Financial Officer, John E. Dugenske, received an award of 4,743 restricted stock units (RSUs) on 10/03/2025 under the 2019 Equity Incentive Plan. Each RSU converts to one share of common stock at no cost to the recipient and the award will vest in three equal installments on 10/03/2026, 10/03/2027, and 10/03/2028. Following the grant, Mr. Dugenske beneficially owns 4,743 shares tied to these RSUs. The Form 4 filing was signed by an attorney-in-fact on 10/07/2025.

Form 144 notice for Allstate Corporation (ALL) reports a proposed sale of 33,614 shares of common stock through Goldman Sachs & Co. LLC on 10/06/2025 on the NYSE. The filing shows the shares were acquired as performance-award compensation on 02/17/2022 (18,989 shares), 02/18/2021 (11,536 shares) and 02/08/2019 (3,089 shares). The table lists an aggregate market value of $7,019,611.62 and a total outstanding share count of 263,505,334. No sales by the reporting person in the prior three months are reported. The filer certifies they are not aware of undisclosed material adverse information and includes the standard Rule 10b5-1/trading-plan notice language.

Margaret M. Keane, a director of The Allstate Corporation (ALL), reported an acquisition of common stock on 10/01/2025. The Form 4 shows she received 160 shares at a price of $210.68 each as an election to take stock instead of cash compensation under the company’s 2017 Equity Compensation Plan for Non-Employee Directors. After the transaction the filing reports 16,276.677 shares beneficially owned (listed with a footnote marker). The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing identifies her relationship to the issuer as Director and indicates this was a one-person Form 4 filing.

Perry M. Traquina, a director of The Allstate Corporation (ALL), reported acquiring 195 shares of common stock on 10/01/2025 at a price of $210.68 per share by electing to receive stock instead of cash compensation under the company’s 2017 Equity Compensation Plan for Non-Employee Directors. After that transaction the reporting person directly beneficially owned 5,407.125 shares. Separately, the filing shows 7,665.992 common share units held under the Amended and Restated Deferred Compensation Plan for Non-Employee Directors, which represent deferred director fees and include dividend-equivalent units; 36.215 of those units were acquired as dividend equivalents for the period 7/03/2025 through 10/01/2025. The form is signed by an attorney-in-fact on behalf of the reporting person.